Kathryn Beckermann, MD, PhD, discusses the patient-reported outcomes for tivozanib plus nivolumab from the phase 3 TiNivo-2 ...

The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its ...

We recently compiled a list of the 11 Most Expensive Stocks Insiders Are Buying Recently. In this article, we are going to ...

A South Korean cohort study shows that rheumatoid arthritis (RA) increases the risk of kidney cancer, particularly in women, ...